We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




mRNA Molecules Localized and Quantified in Fixed Samples

By LabMedica International staff writers
Posted on 20 Sep 2011
Print article
Image: A multiplex image of HER2 mRNA (red), and Beta Actin mRNA (green) with a DAPI nuclear stain (blue). Cells are from the human breast cancer SK-BR-3 cell line, which overexpress HER2 (Photo courtesy of Ryan D.Brady, Biosearch Technologies, Inc.).
Image: A multiplex image of HER2 mRNA (red), and Beta Actin mRNA (green) with a DAPI nuclear stain (blue). Cells are from the human breast cancer SK-BR-3 cell line, which overexpress HER2 (Photo courtesy of Ryan D.Brady, Biosearch Technologies, Inc.).
A RNA visualization method allows simultaneous detection, localization, and quantification of individual mRNA molecules at the sub-cellular level in fixed samples.

By resolving in situ messenger RNA into clear focus, Stellaris fluorescence in situ hybridization (FISH) advances research in cancer, developmental biology, and pathology. By enabling scientists to localize and count discrete molecules of mRNA using widefield fluorescence microscopy, the probes can lead also to streamlined studies in stem cell, pathology, transcription regulation, and neuroscience research.

Stellaris FISH is an effective tool for several key applications. For example, Stellaris probes are used to reveal up- and down- regulation of gene expression in drug screening studies. It can also be used to characterization tumors by correlating mRNA levels of known oncogenes.

Biosearch Technologies, Inc. (Biosearch; Novato, CA, USA), a supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, released the new product, Stellaris FISH Probes, which is currently manufactured on a custom basis. Stellaris FISH probes include software for optimum probe design. In addition, premade probe sets for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in human and mouse applications are available.

A probe set comprises multiple oligonucleotides with different sequences each with a fluorescent label that collectively bind along the same target transcript to produce a punctate signal. This direct detection method minimizes the possibility of false negatives and false positives. Furthermore, Stellaris FISH probes can bind to partially degraded target mRNAs making them well suited for formalin-fixed, paraffin-embedded (FFPE) tissue samples.

Stellaris FISH can also be combined with existing technologies such as quantitative polymerase chain reaction (qPCR), DNA FISH, immunohistochemistry (IHC), and western blotting to provide complementary information.

The Stellaris FISH technology follows a simple protocol, does not use exotic reagents, is inexpensive and platform-independent, offers same-day results, and is versatile toward many sample types and applications. Scientists may even label Stellaris FISH probes with different dyes, to allow for simultaneous multiplex detection of different RNA targets simultaneously. Scientists can address the stochastic nature of gene expression and visualize RNA through direct detection without isolation, purification, and amplification.

Related Links:

Biosearch Technologies, Inc.



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P
New
Quantitative Immunoassay Analyzer
AS050

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.